The short answer: Claustrophobia affects a minority of hyperbaric users. A 2023 systematic review of HBOT adverse effects found it reported in only 3 of 24 trials, at a rate not statistically different from controls (RR 2.94, 95% CI 0.40–7.94), while an older report cites 15% in single-occupancy chambers. Chamber design and a five-minute briefing prevent most of it.
Anxiety about the chamber is the most common reason people hesitate before a first session, and it is a reasonable thing to raise. The honest picture is more encouraging than the fear suggests and more specific than “you will be fine”: the numbers depend heavily on what kind of chamber you are in, most reactions happen in the first few minutes, and nearly all of them are preventable with preparation rather than medication.
This guide separates what the trials measured from what operators see, explains why a narrow horizontal tube produces a different experience than a seated chamber with large windows, and sets out the protocol that keeps a nervous first-timer comfortable.
Disclosure: Superhuman Chambers manufactures and sells hyperbaric chambers for wellness operators and home use. This article summarizes published research and operator practice and is not medical advice. Diagnosed claustrophobia and panic disorder are medical conditions, and decisions about sedation or about proceeding with treatment belong with a physician.
How common is claustrophobia in HBOT, really
Reported rates range from a single case in a trial arm to 15% of patients, and the spread is explained mostly by chamber type and by who was screened out beforehand.
The best current pooled evidence comes from a 2023 systematic review and meta-analysis of HBOT adverse effects published in Frontiers in Medicine, which examined randomized trials across a range of indications and pressures. Claustrophobia was reported in 3 of the included trials. Pooled, the incidence was not significantly different between HBOT and control groups: RR 2.94, 95% CI 0.40–7.94, p > 0.05, with no heterogeneity between studies.
| Source | Setting | Claustrophobia reported |
|---|---|---|
| Chen et al. 2023, systematic review | 3 trials reporting the outcome | RR 2.94 (95% CI 0.40–7.94), not significant |
| Kaur et al. 2012 | Chronic nonhealing ulcer, 2.5 ATA, 30 sessions, n=15 | 2 participants |
| Kraft et al. 2021 | Airway stenosis, 2.0 ATA, 20 sessions, n=10 | 1 participant |
| Miller et al. 2015 | Post-concussive symptoms, 1.5 ATA, 40 sessions | 1 case, in the sham arm |
| Liu et al. 2012, Undersea Hyperb Med | Routine HBO treatment, single-occupancy chambers | Cites 15% incidence |
Two features of that table are worth reading carefully. The Miller case occurred in the control group, whose participants also entered the chamber for a sham exposure, which tells you the trigger is the enclosure rather than the oxygen. And the review’s authors note a screening effect: claustrophobia is treated as a contraindication in many protocols, so people with a known history are frequently excluded before enrollment. The trial numbers therefore describe people who did not expect a problem, while the 15% figure describes routine clinical practice in the most confining chamber format.
Major clinical centers describe it the same way. Mayo Clinic lists anxiety in an enclosed space among the possible effects of treatment, and Cleveland Clinic is more specific: monoplace chambers are small and confined, which can trigger claustrophobia, with anxiety or panic attacks as the possible result. Neither describes it as common, and both treat it as manageable.
What the first five minutes actually feel like
Almost all anxiety in a hyperbaric session appears during compression, in the first three to five minutes, and it is driven by sensory novelty rather than by any real restriction.
Compression is the part nobody describes accurately in advance. The chamber gets noticeably warmer, because compressing gas releases heat. The air fills the ears the way a descending aircraft does, and you clear them by swallowing, yawning, or a gentle Valsalva. There is a continuous flow noise from the gas supply. Your voice sounds slightly different. None of these are signs of a problem, but a person who was not told to expect them will interpret them as one, and that interpretation is what turns discomfort into panic.
Once pressure stabilizes, the sensations stop. The rest of a session, typically 60 to 120 minutes depending on protocol, is quiet and uneventful, which is why many people sleep through it. Our article on what to expect in a first HBOT session walks through the sequence step by step, and the side effects and contraindications guide covers ear clearance in more detail, since unresolved ear pressure is a far more common reason to interrupt a session than anxiety is.
The other thing worth knowing in advance: you are never sealed in alone without contact. Chambers carry two-way communication, staff observe the session continuously, and the operator can begin decompression at any point. Knowing the exit exists is, in practice, the single most effective reason people do not need it.
Why chamber design changes the answer
The same person can be perfectly comfortable in one chamber and unable to tolerate another, and the variables are diameter, posture, and what you can see.
Monoplace tubes are the hardest format. In the classic clinical design the patient lies supine and slides into a narrow cylinder, with the ceiling of the chamber close to the face and no ability to sit up or change posture. That format produces the highest reported rates, and it is the one Cleveland Clinic singles out. Our monoplace chamber guide covers the format in full.
Seated chambers change the experience substantially. Sitting upright restores the postural cues people associate with being in a room rather than being enclosed, allows a person to shift position, read, or use a device, and moves the nearest surface away from the face. Operators consistently report that clients who decline a lie-down tube will accept a seated session, which is the practical case for the seated vertical format.
Window area and interior volume do the rest. Large acrylic viewports keep the room, and the technician, in view, which removes the sense of isolation that drives most of the reaction. A larger internal volume and a companion seat matter for the same reason: a two-seat chamber lets an anxious first-timer bring a partner, a parent, or a coach inside for the session. That is why multi-seat hard-shell designs such as the Superhuman T2 tend to be the easiest sell to clients who are nervous, and why the 2023 review notes that intolerance of a monoplace chamber may warrant referral to a multiplace facility rather than abandoning treatment.
What actually prevents it
Preparation, control, and pacing prevent most reactions, and each one is a protocol choice rather than a personality trait.
- Walk the chamber before the session. Sitting inside with the door open, at ambient pressure, with no time pressure, resolves more anxiety than any explanation. Let the person open and close the door themselves.
- Narrate compression in advance. Warmth, ear fullness, gas noise, voice change, three to five minutes. A person who predicted the sensation does not interpret it as danger.
- Confirm the intercom works while they are watching. The knowledge that a request will be heard immediately is what makes the enclosure tolerable.
- Slow the compression rate. Ear clearance and anxiety both improve when pressure is added gradually, and a slower first descent costs a few minutes.
- Shorten the first session. A 20-minute successful exposure builds tolerance for a full protocol far more reliably than a 90-minute struggle.
- Give them something to do. Music, audio, or video removes the attentional loop that feeds anxiety. The 2023 review lists coaching first among management strategies for exactly this reason.
- Keep a person in view. Visible staff through the viewport does more than a reassurance delivered before the door closes.
When medication or a different chamber is the right call
A minority of people need more than coaching, and both of the recognized options belong to a clinician rather than to a front desk.
Mayo Clinic states directly that a person anxious about the enclosed space may be given a medication to help them relax before treatment. The 2023 systematic review reaches the same conclusion, describing claustrophobia as manageable with coaching and anxiolytic medications, and adding that intolerance of a monoplace chamber may justify referral to the nearest multiplace facility. Both of those are medical decisions: prescribing sits with a physician, and a sedated client changes the monitoring requirements for the session.
There is also a legitimate stopping point. Severe claustrophobia is listed as a relative contraindication in many hyperbaric protocols, and a person who has a panic response to a seated chamber with the door open is not someone to talk into a pressurized session. Declining that booking is the correct clinical and commercial decision.
What operators should build into the protocol
Treat anxiety as a workflow problem with a documented answer, not as something the technician improvises.
| Stage | What to do | Why it matters |
|---|---|---|
| Intake | Ask directly about claustrophobia, panic attacks, and MRI tolerance | MRI history is the best available proxy and surfaces the issue early |
| Pre-session | Open-door chamber tour, compression briefing, intercom test | Removes the two triggers that cause most reactions |
| First session | Shorter exposure, slower compression, staff in view | Builds tolerance instead of testing it |
| During | Continuous observation, immediate response on the intercom | The perceived exit is what makes the enclosure tolerable |
| Abort | A written, rehearsed decompression procedure every operator knows | Hesitation during a panic response is what turns it into a bad experience |
| After | Debrief and re-book at a shorter duration | Most people who struggle once complete the next session |
Two documentation points follow from this. Record the anxiety screen alongside the standard hyperbaric contraindications, because it belongs in the same intake, and rehearse the abort procedure the same way you rehearse any emergency drill. The broader operating and code requirements sit in our hyperbaric chamber safety pillar.
Limitations and open questions
- Trial numbers understate real-world rates. Claustrophobia is a screening exclusion in many protocols, so randomized trials describe a population already filtered for it.
- The pooled estimate is imprecise. Three trials and a confidence interval running from 0.40 to 7.94 cannot establish an incidence in either direction.
- The 15% figure describes single-occupancy chambers in one report and should not be applied to seated or multi-seat designs.
- No trial has compared chamber formats head to head for anxiety, so the design advantages described here rest on physiology and operator experience rather than randomized data.
- Definitions vary. Studies count anything from mild discomfort to a terminated session under the same label, which is part of why reported rates differ so widely.
What this means for wellness operators
Anxiety about the chamber is a conversion problem before it is a clinical one, and it is solved with the same tools that make the session safe.
Most people who ask “will I feel trapped?” are not describing diagnosed claustrophobia. They are describing an unfamiliar enclosure they have only seen in photographs. An open-door tour, an honest description of compression, and a confirmed intercom convert nearly all of them, and cost nothing but five minutes of staff time.
Equipment then decides how many of the remainder you keep. A seated chamber with large viewports and room for a second person answers the objection structurally, in a way no amount of reassurance can, which is worth weighing when comparing formats and reading our guide on what wellness operators evaluate before buying.
And keep the referral line clear. A client whose anxiety does not settle needs a physician conversation or a multiplace facility, not persuasion. To talk through which chamber format suits a nervous client base, contact the team.
References
- Chen S, Wang Y, Yang Y, et al. Adverse effects of hyperbaric oxygen therapy: a systematic review and meta-analysis. Front Med (Lausanne). 2023;10:1160774. https://pmc.ncbi.nlm.nih.gov/articles/PMC10232961/
- Liu WW, Liu K, Mao D, Xu WG, Tao HY. Claustrophobia during routine hyperbaric oxygen treatment. Undersea Hyperb Med. 2012;39(1):619–620. PMID 22400453. https://pubmed.ncbi.nlm.nih.gov/22400453/
- Mayo Clinic. Hyperbaric oxygen therapy: risks and what to expect. Updated December 6, 2024. https://www.mayoclinic.org/tests-procedures/hyperbaric-oxygen-therapy/about/pac-20394380
- Cleveland Clinic. Hyperbaric Oxygen Therapy: what it is, benefits, side effects. https://my.clevelandclinic.org/health/treatments/17811-hyperbaric-oxygen-therapy
- University of Iowa Hospitals and Clinics. Medical risks of hyperbaric oxygen therapy. https://uihc.org/educational-resources/medical-risks-hyperbaric-oxygen-therapy
- Cleveland Clinic. Claustrophobia: symptoms, causes and treatment. https://my.clevelandclinic.org/health/diseases/21746-claustrophobia